Medical Resource Usage for COVID-19 Evaluated Using the National Database of Health Insurance Claims and Specific Health Checkups of Japan

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2024 May 13

PMID 38739628

Authors

Keita Fukuyama

Yukiko Mori

Hiroaki Ueshima

Shiho Ito

Masaki Tanabe

Tomohiro Kuroda

Affiliations

Soon will be listed here.

Abstract

Purpose: The coronavirus disease 2019 (COVID-19) pandemic exhibited several different waves threatening global health care. During this pandemic, medical resources were depleted. However, the kind of medical resources provided to each wave was not clarified. This study aimed to examine the characteristics of medical care provision at COVID-19 peaks in preparation for the next pandemic.

Methods: Using medical insurance claim records in Japan, we examined the presence or absence of COVID-19 infection and the use of medical resources for all patients monthly by age group.

Results: The wave around August 2021 with the Delta strain had the strongest impact on the working population in terms of hospital admission and respiratory support. For healthcare providers, this peak had the highest frequency of severely ill patients. In the subsequent wave, although the number of patients with COVID-19 remained high, they were predominantly older adults, with relatively fewer patients receiving intensive care.

Conclusions: In future pandemics, we should refer to the wave around August 2021 as a situation of medical resource shortage resulting from the COVID-19 pandemic.

References

Cornish N, Bachmann L, Diekema D, McDonald L, McNult P, Stevens-Garcia J . Pandemic Demand for SARS-CoV-2 Testing Led to Critical Supply and Workforce Shortages in U.S. Clinical and Public Health Laboratories. J Clin Microbiol. 2023; 61(7):e0318920. PMC: 10358151. DOI: 10.1128/jcm.03189-20. View

Shukar S, Zahoor F, Hayat K, Saeed A, Gillani A, Omer S . Drug Shortage: Causes, Impact, and Mitigation Strategies. Front Pharmacol. 2021; 12:693426. PMC: 8299364. DOI: 10.3389/fphar.2021.693426. View

Miyashita K, Hozumi H, Furuhashi K, Nakatani E, Inoue Y, Yasui H . Changes in the characteristics and outcomes of COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study. Emerg Microbes Infect. 2022; 12(1):2155250. PMC: 9788709. DOI: 10.1080/22221751.2022.2155250. View

Xia S, Wang L, Zhu Y, Lu L, Jiang S . Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages. Signal Transduct Target Ther. 2022; 7(1):241. PMC: 9295084. DOI: 10.1038/s41392-022-01105-9. View

Cassetti M, Pierson T, Patterson L, Bok K, DeRocco A, Deschamps A . Prototype Pathogen Approach for Vaccine and Monoclonal Antibody Development: A Critical Component of the NIAID Plan for Pandemic Preparedness. J Infect Dis. 2022; 227(12):1433-1441. PMC: 9384504. DOI: 10.1093/infdis/jiac296. View

Manathunga S, Abeyagunawardena I, Dharmaratne S . A comparison of transmissibility of SARS-CoV-2 variants of concern. Virol J. 2023; 20(1):59. PMC: 10067514. DOI: 10.1186/s12985-023-02018-x. View

Machida M, Nishioka Y, Noda T, Imamura T . Research note changes in the number of outpatient visits in Japan during the COVID-19 pandemic. BMC Res Notes. 2023; 16(1):70. PMC: 10158698. DOI: 10.1186/s13104-023-06336-9. View

Argenziano M, Fischkoff K, Smith C . Surgery Scheduling in a Crisis. N Engl J Med. 2020; 382(23):e87. PMC: 7262972. DOI: 10.1056/NEJMc2017424. View

Hoshino N, Hida K, Fukui Y, Takahashi Y, Nakayama T, Obama K . Relationship between diverting stoma and adjuvant chemotherapy in patients with rectal cancer: a nationwide study using the National Database of Health Insurance Claims and Specific Health Checkups of Japan. Int J Clin Oncol. 2021; 27(3):545-552. DOI: 10.1007/s10147-021-02079-4. View

10.

Lam S, Suen L, Cheung T . Global risk to the community and clinical setting: Flocking of fake masks and protective gears during the COVID-19 pandemic. Am J Infect Control. 2020; 48(8):964-965. PMC: 7219383. DOI: 10.1016/j.ajic.2020.05.008. View

11.

Wu H, Huang J, Zhang C, He Z, Ming W . Facemask shortage and the novel coronavirus disease (COVID-19) outbreak: Reflections on public health measures. EClinicalMedicine. 2020; 21:100329. PMC: 7129293. DOI: 10.1016/j.eclinm.2020.100329. View

12.

Rosenbaum L . Facing Covid-19 in Italy - Ethics, Logistics, and Therapeutics on the Epidemic's Front Line. N Engl J Med. 2020; 382(20):1873-1875. DOI: 10.1056/NEJMp2005492. View

13.

Uemura K, Kanata T, Ono S, Michihata N, Yasunaga H . The disease severity of COVID-19 caused by Omicron variants: A brief review. Ann Clin Epidemiol. 2024; 5(2):31-36. PMC: 10944996. DOI: 10.37737/ace.23005. View

14.

Ohtera S, Kato G, Ueshima H, Mori Y, Nakatani Y, Ozasa N . A nationwide survey on participation in cardiac rehabilitation among patients with coronary heart disease using health claims data in Japan. Sci Rep. 2021; 11(1):20096. PMC: 8505519. DOI: 10.1038/s41598-021-99516-1. View

15.

Gannon W, Stokes J, Francois S, Patel Y, Pugh M, Benson C . Association between Availability of Extracorporeal Membrane Oxygenation and Mortality in Patients with COVID-19 Eligible for Extracorporeal Membrane Oxygenation: A Natural Experiment. Am J Respir Crit Care Med. 2022; 205(11):1354-1357. PMC: 9873115. DOI: 10.1164/rccm.202110-2399LE. View

16.

Ranney M, Griffeth V, Jha A . Critical Supply Shortages - The Need for Ventilators and Personal Protective Equipment during the Covid-19 Pandemic. N Engl J Med. 2020; 382(18):e41. DOI: 10.1056/NEJMp2006141. View

17.

Amirian E . Prioritizing COVID-19 test utilization during supply shortages in the late phase pandemic. J Public Health Policy. 2022; 43(2):320-324. PMC: 9002027. DOI: 10.1057/s41271-022-00348-8. View

18.

Idogawa M, Tange S, Nakase H, Tokino T . Interactive Web-based Graphs of Coronavirus Disease 2019 Cases and Deaths per Population by Country. Clin Infect Dis. 2020; 71(15):902-903. PMC: 7197615. DOI: 10.1093/cid/ciaa500. View

19.

Suzuki T, Aizawa K, Shibuya K, Yamanaka S, Anzai Y, Kurokawa K . Prevalence of Asymptomatic SARS-CoV-2 Infection in Japan. JAMA Netw Open. 2022; 5(12):e2247704. PMC: 9856923. DOI: 10.1001/jamanetworkopen.2022.47704. View

20.

Hirae K, Hoshina T, Koga H . Impact of the COVID-19 pandemic on the epidemiology of other communicable diseases in Japan. Int J Infect Dis. 2023; 128:265-271. PMC: 9837205. DOI: 10.1016/j.ijid.2023.01.013. View